Strategies for delivering bone morphogenetic protein for bone healing

Area of Science:

• Orthopedic Surgery
• Biomaterials Science
• Regenerative Medicine

Background:

• Bone morphogenetic proteins (BMPs) are key growth factors within the Transforming Growth Factor Beta (TGF-β) superfamily.
• FDA-approved BMP-2 and BMP-7 are utilized in spinal fusion and long-bone fracture treatments, often with collagen carriers.
• Current applications include spinal fusion, oral/maxillofacial surgery, and long bone defect repair.

Purpose of the Study:

• To review the current status of BMPs in orthopedic surgery.
• To discuss the role of carriers in BMP efficacy and delivery.
• To identify prospects and challenges for BMPs in bone healing.

Main Methods:

• Literature review of BMP applications, carriers, and clinical outcomes.
• Analysis of BMP loading and release kinetics research.
• Synthesis of findings on BMP success and limitations in orthopedics.

Main Results:

• BMPs show significant potential for bone healing, evidenced by animal studies.
• Carrier selection is critical for BMP efficiency, with various natural and synthetic materials employed.
• Optimal dosage, scaffold, and administration routes require further clinical investigation.

Conclusions:

• While BMPs hold promise for orthopedic applications, further clinical research is essential.
• Establishing the efficacy and application of BMPs with appropriate carriers and doses is ongoing.
• Addressing limitations and challenges will enhance the future use of BMPs in bone repair.